As noted, ARNI is recommended for HFrEF, while GDF11 and EVs synergistically improve ventricular systolic function via anti-myocardial hypertrophy and inhibiting myocardial fibrosis, respectively. The gene discussed is GDF11; the disease is cardiac hypertrophy.